SCHEMBL19465293

SCHEMBL19465293

N[C@H]1CN(CC(=O)OCc2ccccc2)CC[C@@H]1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ NPC1 O15118 4/20 0.46
▸ RAB9A P51151 4/20 0.46
▸ CYP2C19 P33261 2/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ CYP2C9 P11712 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2D6 P10635 1/20 0.40
▸ GRIN2B Q13224 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ CHRM5 P08912 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ CHRM3 P20309 1/20 0.40
▸ CTSL P07711 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23733552 0.93 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9ACYP2C19ALDH1A1
SCHEMBL18909590 0.86 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9ACYP2C19ALDH1A1
SCHEMBL22280532 0.86 LTA4H (0.48) SMN1; SMN2NPC1RAB9ACYP2C19ALDH1A1
SCHEMBL23027037 0.86 LTA4H (0.48) SMN1; SMN2NPC1RAB9ACYP2C19ALDH1A1
SCHEMBL21100502 0.85 ALDH1A1 (0.43) SMN1; SMN2NPC1RAB9ACYP2C19ALDH1A1
SCHEMBL21165288 0.85 ALDH1A1 (0.43) SMN1; SMN2NPC1RAB9ACYP2C19ALDH1A1
SCHEMBL21100503 0.85 ALDH1A1 (0.43) SMN1; SMN2NPC1RAB9ACYP2C19ALDH1A1
SCHEMBL21100504 0.85 ALDH1A1 (0.43) SMN1; SMN2NPC1RAB9ACYP2C19ALDH1A1
SCHEMBL21100933 0.84 LTA4H (0.48) SMN1; SMN2NPC1RAB9ACYP2C19ALDH1A1
SCHEMBL16900141 0.83 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9ACYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790229-B2 Bruton's tyrosine kinase inhibitors SUNESIS PHARMACEUTICALS, INC. (US) 2017-10-17 — — US disclosed
Send feedback